Page last updated: 2024-10-27

gbr 12935 and Atherosclerotic Parkinsonism

gbr 12935 has been researched along with Atherosclerotic Parkinsonism in 2 studies

1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Massie, A1
Goursaud, S1
Schallier, A1
Vermoesen, K1
Meshul, CK1
Hermans, E1
Michotte, Y1
Ossowska, K1
Wardas, J1
Smiałowska, M1
Kuter, K1
Lenda, T1
Wierońska, JM1
Zieba, B1
Nowak, P1
Dabrowska, J1
Bortel, A1
Kwieciński, A1
Wolfarth, S1

Other Studies

2 other studies available for gbr 12935 and Atherosclerotic Parkinsonism

ArticleYear
Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats.
    Neurochemistry international, 2010, Volume: 57, Issue:5

    Topics: Animals; Aspartic Acid; Blotting, Western; Chromatography, High Pressure Liquid; Corpus Striatum; Do

2010
A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
    The European journal of neuroscience, 2005, Volume: 22, Issue:6

    Topics: Algorithms; Animals; Autoradiography; Caudate Nucleus; Dopamine; Herbicides; Male; Neurons; Neurotra

2005